Obesity and metabolic inflammation
- PMID: 24003334
- PMCID: PMC3758492
- DOI: 10.1016/j.ddmec.2013.03.006
Obesity and metabolic inflammation
Abstract
Obesity epidemics affect 35.7% of adults and approximately 17% of children in the United States. Obesity has been associated with several health disorders, such as type 2 diabetes, cardiovascular diseases, fatty liver disease, and certain forms of cancer. Medical costs associated with obesity were estimated at $147 billion in 2008. Chronic tissue inflammation, particularly in adipose tissue, has been considered as a key underlying mechanism for the development of obesity-related metabolic syndrome. In this review, we discuss the recent progress in the field of metabolic inflammation and the potential implication of anti-inflammation approaches as therapeutic interventions for treating obesity-related metabolic disorders.
Keywords: WAT; inflammation; obesity.
Conflict of interest statement
The author declares no conflict of interest.
Figures
Similar articles
-
Potential of Nutraceutical Supplementation in the Modulation of White and Brown Fat Tissues in Obesity-Associated Disorders: Role of Inflammatory Signalling.Int J Mol Sci. 2021 Mar 25;22(7):3351. doi: 10.3390/ijms22073351. Int J Mol Sci. 2021. PMID: 33805912 Free PMC article. Review.
-
Recent advances in the relationship between obesity, inflammation, and insulin resistance.Eur Cytokine Netw. 2006 Mar;17(1):4-12. Eur Cytokine Netw. 2006. PMID: 16613757 Review.
-
Precision Nutrition to Activate Thermogenesis as a Complementary Approach to Target Obesity and Associated-Metabolic-Disorders.Cancers (Basel). 2021 Feb 18;13(4):866. doi: 10.3390/cancers13040866. Cancers (Basel). 2021. PMID: 33670730 Free PMC article. Review.
-
Metabolic tissue-resident CD8+ T cells: A key player in obesity-related diseases.Obes Rev. 2021 Mar;22(3):e13133. doi: 10.1111/obr.13133. Epub 2020 Sep 15. Obes Rev. 2021. PMID: 32935464 Review.
-
Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice.Sci Rep. 2016 Aug 22;6:31542. doi: 10.1038/srep31542. Sci Rep. 2016. PMID: 27545964 Free PMC article.
Cited by
-
Cardiovascular and lipid-lowering effects of a marine lipoprotein extract in a high-fat diet-induced obesity mouse model.Int J Med Sci. 2023 Jan 22;20(3):292-306. doi: 10.7150/ijms.80727. eCollection 2023. Int J Med Sci. 2023. PMID: 36860672 Free PMC article.
-
Association of a Large Panel of Cytokine Gene Polymorphisms with Complications and Comorbidities in Type 2 Diabetes Patients.J Diabetes Res. 2015;2015:605965. doi: 10.1155/2015/605965. Epub 2015 May 6. J Diabetes Res. 2015. PMID: 26064986 Free PMC article.
-
Renal-Protective Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone in ob/ob Mice.Med Sci Monit. 2019 Mar 1;25:1582-1589. doi: 10.12659/MSM.913461. Med Sci Monit. 2019. PMID: 30820023 Free PMC article.
-
The Role of Uterine Natural Killer Cells on Recurrent Miscarriage and Recurrent Implantation Failure: From Pathophysiology to Treatment.Biomedicines. 2021 Oct 9;9(10):1425. doi: 10.3390/biomedicines9101425. Biomedicines. 2021. PMID: 34680540 Free PMC article. Review.
-
Taurodeoxycholic acid and valine reverse obesity-associated augmented alloimmune responses and prolong allograft survival.Am J Transplant. 2022 Feb;22(2):402-413. doi: 10.1111/ajt.16856. Epub 2021 Oct 17. Am J Transplant. 2022. PMID: 34551205 Free PMC article.
References
-
- Hotamisligil GS, et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259 (5091):87–91. - PubMed
-
- Gao Z, et al. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem. 2002;277 (50):48115–48121. - PubMed
-
- Lee YH, et al. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem. 2003;278 (5):2896–2902. - PubMed
-
- Schipper HS, et al. Adipose tissue-resident immune cells: key players in immunometabolism. Trends Endocrinol Metab. 2012;23 (8):407–415. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources